Insider Sale by Catinazzo Thomas (Chief Financial Officer)
Trade Summary
2 days ago, Catinazzo Thomas, serving as Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 17,717 shares at $18.94 per share, for a total transaction value of $335,559.98. Following this transaction, Catinazzo Thomas now holds 122,851 shares of RLAY.
This sale represents a 12.60% decrease in Catinazzo Thomas's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Tuesday, September 8, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 9, 2026 at 4:15 PM ET, 1 day after the trade was made.
Relay Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$18.94
Quantity
17,717
Total Value
$335,559.98
Shares Owned
122,851
Trade Date
2 days ago
SEC Filing Date
at 4:15 PM ET
Filed 1 day after trade
Discussion